cetylpyridinium chloride anhydrous has been researched along with norethindrone acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C | 1 |
| Christodoulakos, G; Creatsa, M; Kaparos, G; Karaflou, M; Lambrinoudaki, I; Rizos, D | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and norethindrone acetate
| Article | Year |
|---|---|
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners | 2010 |
Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.
Topics: Androstenes; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Progestins | 2010 |